"Designing Growth Strategies is in our DNA"
Region : Global | Published Date: Upcoming | Report ID: FBI100700| Status : Upcoming
A contrast agent referred to as contrast medium, is a substance used to increase the contrast of structures of fluids in the body during medical imaging. Contrast agents enhance the visibility of the targeted tissues, structures or blood vessels. Contrast agents alter or absorb external electromagnetism or ultrasound, which further emits radiation themselves. Barium-based contrast media, iodinated contrast media, gadolinium-based contrast media and microbubble contrast media are generally used contrast agents during MRI and ultrasound. Increasing prevalence of cancer, neurological and cardiovascular diseases, growing partnerships and acquisition among players to launch new products, and emerging innovations in contrast media are some of the factors likely to boost the global contrast media market during the forecast period.
Growing demand for image-guided diagnostics and procedures, increasing incidence & prevalence of cardiac diseases, and cancer, technological advancements in medical imaging techniques are some of the major driving the growth of contrast media market during the forecast period.
To get information on various segments, share your queries with us
However, due to the side effects associated while using contrast media such as stomach cramps, vomiting, bluish skin color etc., and high cost of the contrast media injectors are some of the factors restraining the growth of the global contrast media market during the forecast period.
Some of the major companies operating in the global contrast media market are AMAG Pharmaceuticals, Bayer AG, Bracco Diagnostic Inc., DAIICHI SANKYO COMPANY, LIMITED., GENERAL ELECTRIC COMPANY, Lantheus Medical Imaging, Inc., Guerbet, Nanoscan Imaging LLC, SANOCHEMIA Pharmazeutika AG, Spago Nanomedical AB., Interpharma Praha, a.s., among others.
· Barium-based Contrast Media
· Iodinated Contrast Media
· Gadolinium-based Contrast Media
· Microbubble Contrast Media
By Route of Administration
By End User
· Ambulatory Surgery Centres
· North America (U.S. and Canada)
· Europe (U.K., Germany, France, Italy, Spain, Scandinavia, and Rest of Europe)
· Asia Pacific (Japan, China, India, Australia, Southeast Asia, and Rest of Asia Pacific)
· Latin America (Brazil, Mexico, and Rest of Latin America)
· Middle East & Africa (South Africa, GCC, and Rest of Middle East & Africa)
Among the route of administration segment, the intravenous segment is anticipated to hold the largest market share during the forecast period as they are the most commonly used route of administration and helps in enhancing the imaging which can be by delineating the surrounding structures while planning the treatment of abdominal and lower esophageal cancers.
Geographically, the global contrast media market can be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa., North America is anticipated to dominate the contrast media market during the forecast period owing to the presence of well-established healthcare infrastructure, and growing investments in research activities by many key players to develop effective contrast media agents. In addition, growing advancements in diagnostic imaging technology, the growing incidence of cancer, and cardiac disorders are likely to drive the growth of the contrast media market in North America during the forecast period. The global contrast media market in Europe and Asia Pacific region is likely to expand at significant CAGR due to increasing application of MRI procedures in cardiovascular diseases, presence of advanced cath-labs and growing prevalence of cardiac disorders.